Table 4.
Type of study | Objective | Result | Year | Ref. |
---|---|---|---|---|
Clinical study | Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas possible role of cannabis inhalation | Spontaneous regression on benign brain tumor may have been associated with cannabis use | 2011 | [100] |
| ||||
Preclinical study | Antitumor activity of abnormal CBD and its analog O-1602 in Taxol-resistant preclinical models of breast cancer | Some cannabinoids acting through some GPCRs inducing apoptosis in breast cancer cell lines | 2019 | [101] |
| ||||
Preclinical study | Antitumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy | THC reduced the viability of cells of hepatocellular carcinoma | 2011 | [90] |
| ||||
Preclinical study | A combined preclinical therapy of cannabinoids and TMZ, against glioma | THC and TMZ exert a strong antitumor effect against glioma | 2011 | [87] |
| ||||
Preclinical study | Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition | Cannabinoids reduced ErbB2-driven breast cancer progression through Akt inhibition | 2010 | [89] |
| ||||
Preclinical study | Δ 9-THC inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo | THC inhibits epithelial growth factor-induced cancer cell migration in vitro as well as its growth and metastases in vivo | 2008 | [88] |
| ||||
Preclinical study | CBD as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells | CBD as novel inhibitor of Id-1 gene expression in aggressive breast cancer cells | 2007 | [102] |
| ||||
Preclinical study | A pilot clinical study of Δ 9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme | THC and other cannabinoids inhibits brain tumor growth | 2006 | [8] |
| ||||
Preclinical study | Δ9-THC-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria | THC-induced apoptosis in leukemic cells | 2006 | [103] |
| ||||
Preclinical study | Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes | CBD administration-induced apoptosis in pancreatic adenocarcinomas | 2006 | [104] |
| ||||
Preclinical study | Cannabinoid receptor-mediated apoptosis induced by R (+)-methanandamide and Win55, 212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma | Cannabinoids induce apoptosis and growth inhibition in mantel cell lymphoma | 2006 | [105] |
| ||||
Preclinical study | Antitumor effects of CBD, a nonpsychoactive cannabinoid, on human glioma cell lines | CBD was able to produce a significant antitumor activity in both in vivo and in vitro conditions | 2004 | [85] |
| ||||
Preclinical study | The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation | Endogenous cannabinoid anandamide inhibits breast cancer cell proliferation | 1998 | [86] |
THC, tetrahydrocannabinol; CBD, cannabidiol, TMZ, temozolomide.